SNYR

Synergy CHC Corp. Common Stock

Basic Materials · Medicinal Chemicals & Botanical Products
$0.26-7.26% today
AI Take · AlgoThesis

SNYR trades at an RSI of 31.0, approaching oversold territory, yet the stock sits far below its 52-week high with minimal short interest at 2.89% of float. The absence of a meaningful P/E ratio suggests either recent profitability struggles or losses, which aligns with a market cap near zero—a red flag for microcap distress. The depressed momentum reading could signal capitulation among retail holders, but without earnings visibility or institutional support, this doesn't necessarily indicate a bargain. The combination of technical weakness, vanishing market value, and lightweight short covering suggests limited catalyst potential in the near term.

Snapshot

Market cap
$4.1M
P/E
Forward P/E
1.0
EPS (TTM)
$-1.36
Dividend yield
Net margin
-57.0%
ROE
-71.6%
RSI (14)
31
Beta
0.72
Short % of float
2.9%
Days to cover
0.2
52w high
No

Recent headlines

Peers in Medicinal Chemicals & Botanical Products

Build a thesis around SNYR

Type a thesis in plain English. AlgoThesis researches it with real data, cites sources, and hands back a tradeable basket.

Open in AlgoThesis →